# MVP Exit-Gate Packet (Issue 1704)

**Project:** Ghidra "Alien-Tech" MVP  
**Date:** 2026-02-21 (UTC)  
**Issue:** 1704 (`E8-S4`, reopen)  
**Branch:** `wc/1704/20260221T014410Z`  
**Workcell:** `wc-1704-20260221T014410Z`

---

## 1. Evidence Bundle

- Primary exit-gate report: `docs/exit-gate-report.md`
- Formal go/no-go artifact: `docs/go-no-go-decision.md`
- Reopened regression + soak evidence: `docs/soak-test-report-1701.md`
- Reopened security evidence: `docs/security/evidence/abuse-scenario-suite-1806/README.md`
- Gate-aligned metric evidence: `docs/research/evaluation-harness.md` (Sections 6.5, 6.6)
- Workcell quality-gate execution: `docs/evidence/exit-gate-packet-1704/quality-gates.md`

## 2. MVP Exit-Gate Register

| Gate ID | Gate (measurable criterion) | Status (`pass`/`fail`/`waived`) | Evidence artifact path |
|---|---|---|---|
| G1 | Receipt completeness (`100%`) | **pass** | `docs/exit-gate-report.md` |
| G2 | Rollback success (`100%`) | **pass** | `docs/exit-gate-report.md` |
| G3 | Search latency (`p95 < 300 ms`) | **pass** | `docs/soak-test-report-1701.md` |
| G4 | Search quality (Recall@10 delta vs stock `>= +0.10`) | **pass** | `docs/soak-test-report-1701.md` |
| G5 | Triage quality (entrypoint/hotspot recall `>= 85%`) | **pass** | `docs/research/evaluation-harness.md` |
| G6 | Security (no direct agent write path) | **pass** | `docs/security/evidence/abuse-scenario-suite-1806/README.md` |
| G7 | CI stability (smoke + regression green) | **pass** | `docs/soak-test-report-1701.md` |

## 3. Quality-Gate Register (Workcell 1704)

| Gate | Status (`pass`/`fail`/`waived`) | Evidence artifact path |
|---|---|---|
| `test` (`bash scripts/cyntra/gates.sh --mode=all`) | **pass** | `docs/evidence/exit-gate-packet-1704/quality-gates.md` |
| `typecheck` (`bash scripts/cyntra/gates.sh --mode=context`) | **pass** | `docs/evidence/exit-gate-packet-1704/quality-gates.md` |
| `lint` (`bash scripts/cyntra/gates.sh --mode=diff`) | **pass** | `docs/evidence/exit-gate-packet-1704/quality-gates.md` |
| `max-diff-size` (diff-check) | **pass** | `docs/evidence/exit-gate-packet-1704/quality-gates.md` |
| `secret-detection` (diff-check) | **pass** | `docs/evidence/exit-gate-packet-1704/quality-gates.md` |

## 4. Open Risks and Waivers

### 4.1 Open Waiver Register

| Waiver ID | Applies To | Owner | Rationale | Expiration/Revisit Condition | Disposition |
|---|---|---|---|---|---|
| W-1704-01 | Production promotion (`C1-C11`) | Release owner (`Issue 1704`) + Security review owner | Internal RC1 release is allowed with documented conditions; production promotion remains blocked until all conditions close. | Revisit at each weekly release review; expires at GA decision gate (no later than 2026-03-31). | **Open** |

### 4.2 Open Residual Risk Register

| Risk ID | Threat | Owner | Rationale | Expiration/Revisit Condition | Current Status |
|---|---|---|---|---|---|
| RR-1704-T1 | Prompt injection (`T1`) | Security review owner | Inherent LLM risk; mitigated by capability guard, policy modes, and human review. | Revalidate at implementation phase gate and before GA promotion. | Accepted (internal RC1 scope) |
| RR-1704-T3 | Compromised model weights (`T3`) | Security review owner | Supply-chain exposure cannot be eliminated; mitigated with provenance controls and phased rollout. | Revalidate during periodic benchmark/security review (`C7`, `C8`). | Accepted (internal RC1 scope) |
| RR-1704-T5 | Cloud data exfiltration (`T5`) | Security review owner | Residual exposure exists in cloud mode; mitigated via explicit opt-in and egress policy controls. | Must be re-approved before enabling production cloud mode (`C3`). | Accepted (internal RC1 scope) |
| RR-1704-T9 | Hallucination-driven incorrect output (`T9`) | Eval/DevOps review owner | Model error cannot be reduced to zero; mitigated with thresholds, validation, and reviewer workflow. | Revalidate on every model/config change and at GA decision gate. | Accepted (internal RC1 scope) |

## 5. Go/No-Go Decision Provenance

### 5.1 Dated Final Determination

| Field | Value |
|---|---|
| Determination date | 2026-02-21 |
| Final determination | **GO for internal MVP RC1 scope** |
| Production determination | **NO-GO until conditions `C1-C11` are closed** |
| Determination basis | All seven MVP exit gates are `pass`, quality gates are `pass`, and residual risks are explicitly accepted for internal scope only. |

### 5.2 Approver Record

| Role | Evidence-backed basis | Decision | Date | Status |
|---|---|---|---|---|
| Project Lead | `docs/exit-gate-report.md` + `docs/go-no-go-decision.md` | GO (internal RC1 scope) | 2026-02-21 | Recorded |
| Security Review Owner | `docs/security/security-signoff-checklist.md` + `docs/security/evidence/abuse-scenario-suite-1806/README.md` | GO (conditional: `C1-C8`) | 2026-02-20 | Approved with conditions |
| Eval/DevOps Review Owner | `docs/soak-test-report-1701.md` + `docs/research/evaluation-harness.md` | GO | 2026-02-21 | Recorded |
| Architecture Review Owner | `docs/go-no-go-decision.md` | GO/NO-GO (production gate) | Pending | Pending signature |
| Legal Review Owner | `docs/go-no-go-decision.md` | GO/NO-GO (production gate) | Pending | Pending signature |
| CISO/Security Sponsor | `docs/go-no-go-decision.md` | GO/NO-GO (production gate) | Pending | Pending signature |

### 5.3 Provenance Cross-Reference

| Decision Claim | Primary Evidence |
|---|---|
| Exit gates pass with measurable criteria | `docs/exit-gate-report.md` Section 2.1 |
| Reopened regression and soak stability are green | `docs/soak-test-report-1701.md` |
| Reopened abuse-scenario suite is passing with no failed controls | `docs/security/evidence/abuse-scenario-suite-1806/README.md` |
| Benchmark and gate-metric alignment | `docs/research/evaluation-harness.md` Sections 3.5, 6.5, 6.6 |
| Formal release decision constraints (`C1-C11`) | `docs/go-no-go-decision.md` Section 3 |
